Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | SQLE | Q14534 | 6/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | FNTB | P49356 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1305497 | 1.00 | KMT2A (0.41) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL465977 | 0.85 | TSHR (0.34) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL465976 | 0.85 | TSHR (0.34) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL7939611 | 0.84 | TSHR (0.50) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL1486008 | 0.78 | KMT2A (0.34) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL1269881 | 0.73 | KMT2A (0.31) | KMT2A | |
| SCHEMBL11762057 | 0.73 | ALDH1A1 (0.40) | KMT2ASQLEALDH1A1FNTAFNTB | |
| SCHEMBL11762052 | 0.73 | ALDH1A1 (0.40) | KMT2ASQLEALDH1A1FNTAFNTB | |
| SCHEMBL1269879 | 0.73 | KMT2A (0.31) | KMT2A | |
| SCHEMBL8850550 | 0.72 | FNTA (0.47) | KMT2ASQLEMAPTMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7012120-B2 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | HENKEL CORPORATION (US) | 2006-03-14 | — | — | US | claimed |
| US-20050288458-A1 | Reworkable thermosetting resin composition | KLEMARCZYK PHILIP T | 2005-12-29 | — | — | US | claimed |
| CN-1232515-C | Reworkable composition of ethylene oxide or thiirane containing resin and curing agent | HENKEL CORP (US) | 2005-12-21 | — | — | CN | claimed |
| CN-1427831-A | Reworkable composition of oxirane (S) or thiirane (S)-containing resin and curing agent | HENKEL LOCTITE CORP (US) | 2003-07-02 | — | — | CN | claimed |
| US-20030073770-A1 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | Henkel IP & Holding GmbH (DE) | 2003-04-17 | — | — | US | claimed |
| US-8053587-B2 | for mounting onto a circuit board semiconductor devices | HENKEL CORPORATION (US) | 2011-11-08 | — | — | US | disclosed |
| US-20080214840-A1 | Reworkable thermosetting resin composition | HENKEL CORPORATION (US) | 2008-09-04 | — | — | US | disclosed |
| US-7012120-B2 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | HENKEL CORPORATION (US) | 2006-03-14 | — | — | US | disclosed |
| US-20050288458-A1 | Reworkable thermosetting resin composition | KLEMARCZYK PHILIP T | 2005-12-29 | — | — | US | disclosed |
| CN-1232515-C | Reworkable composition of ethylene oxide or thiirane containing resin and curing agent | HENKEL CORP (US) | 2005-12-21 | — | — | CN | disclosed |
| CN-1427831-A | Reworkable composition of oxirane (S) or thiirane (S)-containing resin and curing agent | HENKEL LOCTITE CORP (US) | 2003-07-02 | — | — | CN | disclosed |
| US-20030073770-A1 | Reworkable compositions of oxirane(s) or thirane(s)-containing resin and curing agent | Henkel IP & Holding GmbH (DE) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214840-A1 | Reworkable thermosetting resin composition | GSS, LSS, LRBA | KMT2A 586/4885SQLE 2948/4885MAPT 1848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.